NCT05582850
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05582850
Title DT-9081 Study in Participants With Advanced, Recurrent or Metastatic Solid Tumours (EPRAD)
Acronym EPRAD
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Domain Therapeutics SA
Indications
Therapies
Age Groups: adult
Covered Countries FRA | BEL

Facility Status City State Zip Country Details
Institut Jules Bordet Anderlecht Belgium Details
Université Catholique de Louvain Leuven Belgium Details
Institut Curie Paris France Details
Institut Claudius Regaud Toulouse France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field